Logo image of CPT

CAMDEN PROPERTY TRUST (CPT) Stock Fundamental Analysis

USA - NYSE:CPT - US1331311027 - REIT

102.66 USD
+0.9 (+0.88%)
Last: 11/14/2025, 8:04:00 PM
102.66 USD
0 (0%)
After Hours: 11/14/2025, 8:04:00 PM
Fundamental Rating

4

Overall CPT gets a fundamental rating of 4 out of 10. We evaluated CPT against 20 industry peers in the Residential REITs industry. While CPT is still in line with the averages on profitability rating, there are concerns on its financial health. CPT is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

CPT had positive earnings in the past year.
CPT had a positive operating cash flow in the past year.
Each year in the past 5 years CPT has been profitable.
In the past 5 years CPT always reported a positive cash flow from operatings.
CPT Yearly Net Income VS EBIT VS OCF VS FCFCPT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

1.2 Ratios

Looking at the Return On Assets, with a value of 2.97%, CPT is in line with its industry, outperforming 60.00% of the companies in the same industry.
CPT's Return On Equity of 5.92% is fine compared to the rest of the industry. CPT outperforms 65.00% of its industry peers.
The Return On Invested Capital of CPT (2.64%) is comparable to the rest of the industry.
The Average Return On Invested Capital over the past 3 years for CPT is in line with the industry average of 2.60%.
Industry RankSector Rank
ROA 2.97%
ROE 5.92%
ROIC 2.64%
ROA(3y)4.38%
ROA(5y)3.73%
ROE(3y)8.22%
ROE(5y)7.1%
ROIC(3y)2.74%
ROIC(5y)2.62%
CPT Yearly ROA, ROE, ROICCPT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20 25

1.3 Margins

With a Profit Margin value of 17.11%, CPT perfoms like the industry average, outperforming 55.00% of the companies in the same industry.
In the last couple of years the Profit Margin of CPT has declined.
CPT has a Operating Margin of 18.25%. This is comparable to the rest of the industry: CPT outperforms 50.00% of its industry peers.
CPT's Operating Margin has declined in the last couple of years.
The Gross Margin of CPT (61.28%) is better than 75.00% of its industry peers.
CPT's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 18.25%
PM (TTM) 17.11%
GM 61.28%
OM growth 3Y-0.89%
OM growth 5Y-4.58%
PM growth 3Y-26.44%
PM growth 5Y-13.1%
GM growth 3Y0.19%
GM growth 5Y-0.06%
CPT Yearly Profit, Operating, Gross MarginsCPT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CPT is destroying value.
CPT has less shares outstanding than it did 1 year ago.
The number of shares outstanding for CPT has been increased compared to 5 years ago.
Compared to 1 year ago, CPT has an improved debt to assets ratio.
CPT Yearly Shares OutstandingCPT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
CPT Yearly Total Debt VS Total AssetsCPT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

CPT has an Altman-Z score of 1.52. This is a bad value and indicates that CPT is not financially healthy and even has some risk of bankruptcy.
CPT has a better Altman-Z score (1.52) than 75.00% of its industry peers.
The Debt to FCF ratio of CPT is 9.72, which is on the high side as it means it would take CPT, 9.72 years of fcf income to pay off all of its debts.
With an excellent Debt to FCF ratio value of 9.72, CPT belongs to the best of the industry, outperforming 95.00% of the companies in the same industry.
CPT has a Debt/Equity ratio of 0.82. This is a neutral value indicating CPT is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.82, CPT is in the better half of the industry, outperforming 65.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.82
Debt/FCF 9.72
Altman-Z 1.52
ROIC/WACC0.36
WACC7.31%
CPT Yearly LT Debt VS Equity VS FCFCPT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.3 Liquidity

CPT has a Current Ratio of 0.07. This is a bad value and indicates that CPT is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.07, CPT is not doing good in the industry: 80.00% of the companies in the same industry are doing better.
CPT has a Quick Ratio of 0.07. This is a bad value and indicates that CPT is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.07, CPT is not doing good in the industry: 75.00% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.07
Quick Ratio 0.07
CPT Yearly Current Assets VS Current LiabilitesCPT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

4

3. Growth

3.1 Past

The earnings per share for CPT have decreased strongly by -42.37% in the last year.
CPT shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 0.43% yearly.
Looking at the last year, CPT shows a small growth in Revenue. The Revenue has grown by 1.55% in the last year.
The Revenue has been growing by 8.46% on average over the past years. This is quite good.
EPS 1Y (TTM)-42.37%
EPS 3Y13.97%
EPS 5Y0.43%
EPS Q2Q%194.12%
Revenue 1Y (TTM)1.55%
Revenue growth 3Y10.52%
Revenue growth 5Y8.46%
Sales Q2Q%2.18%

3.2 Future

The Earnings Per Share is expected to grow by 0.69% on average over the next years.
Based on estimates for the next years, CPT will show a small growth in Revenue. The Revenue will grow by 4.51% on average per year.
EPS Next Y-10.21%
EPS Next 2Y-11.47%
EPS Next 3Y0.69%
EPS Next 5YN/A
Revenue Next Year2.44%
Revenue Next 2Y2.5%
Revenue Next 3Y3.27%
Revenue Next 5Y4.51%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CPT Yearly Revenue VS EstimatesCPT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B 2B
CPT Yearly EPS VS EstimatesCPT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6 8

2

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 50.32, CPT can be considered very expensive at the moment.
The rest of the industry has a similar Price/Earnings ratio as CPT.
CPT's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 25.89.
Based on the Price/Forward Earnings ratio of 69.67, the valuation of CPT can be described as expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CPT indicates a slightly more expensive valuation: CPT is more expensive than 60.00% of the companies listed in the same industry.
CPT's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 34.59.
Industry RankSector Rank
PE 50.32
Fwd PE 69.67
CPT Price Earnings VS Forward Price EarningsCPT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

CPT's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. CPT is cheaper than 80.00% of the companies in the same industry.
85.00% of the companies in the same industry are more expensive than CPT, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 28.52
EV/EBITDA 16.45
CPT Per share dataCPT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)116.75
EPS Next 2Y-11.47%
EPS Next 3Y0.69%

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 4.13%, CPT is a good candidate for dividend investing.
CPT's Dividend Yield is slightly below the industry average, which is at 7.22.
CPT's Dividend Yield is rather good when compared to the S&P500 average which is at 2.42.
Industry RankSector Rank
Dividend Yield 4.13%

5.2 History

The dividend of CPT has a limited annual growth rate of 4.99%.
CPT has been paying a dividend for at least 10 years, so it has a reliable track record.
CPT has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)4.99%
Div Incr Years7
Div Non Decr Years14
CPT Yearly Dividends per shareCPT Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3 4

5.3 Sustainability

170.91% of the earnings are spent on dividend by CPT. This is not a sustainable payout ratio.
CPT's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP170.91%
EPS Next 2Y-11.47%
EPS Next 3Y0.69%
CPT Yearly Income VS Free CF VS DividendCPT Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M
CPT Dividend Payout.CPT Dividend Payout, showing the Payout Ratio.CPT Dividend Payout.PayoutRetained Earnings

CAMDEN PROPERTY TRUST

NYSE:CPT (11/14/2025, 8:04:00 PM)

After market: 102.66 0 (0%)

102.66

+0.9 (+0.88%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryResidential REITs
Earnings (Last)11-06 2025-11-06/amc
Earnings (Next)02-04 2026-02-04/amc
Inst Owners96.78%
Inst Owner Change-1.15%
Ins Owners1.25%
Ins Owner Change0.94%
Market Cap10.97B
Revenue(TTM)1.57B
Net Income(TTM)268.55M
Analysts72.67
Price Target123.59 (20.39%)
Short Float %2.77%
Short Ratio3.31
Dividend
Industry RankSector Rank
Dividend Yield 4.13%
Yearly Dividend4.15
Dividend Growth(5Y)4.99%
DP170.91%
Div Incr Years7
Div Non Decr Years14
Ex-Date09-30 2025-09-30 (1.05)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)121.26%
Min EPS beat(2)-0.59%
Max EPS beat(2)243.11%
EPS beat(4)2
Avg EPS beat(4)58.98%
Min EPS beat(4)-12.31%
Max EPS beat(4)243.11%
EPS beat(8)4
Avg EPS beat(8)90.86%
EPS beat(12)8
Avg EPS beat(12)76.46%
EPS beat(16)9
Avg EPS beat(16)99.25%
Revenue beat(2)0
Avg Revenue beat(2)-1.09%
Min Revenue beat(2)-1.74%
Max Revenue beat(2)-0.45%
Revenue beat(4)0
Avg Revenue beat(4)-0.97%
Min Revenue beat(4)-1.74%
Max Revenue beat(4)-0.45%
Revenue beat(8)0
Avg Revenue beat(8)-1.04%
Revenue beat(12)0
Avg Revenue beat(12)-0.97%
Revenue beat(16)2
Avg Revenue beat(16)5.1%
PT rev (1m)-0.63%
PT rev (3m)-4.98%
EPS NQ rev (1m)-17.84%
EPS NQ rev (3m)-6.45%
EPS NY rev (1m)10.27%
EPS NY rev (3m)29.82%
Revenue NQ rev (1m)-0.06%
Revenue NQ rev (3m)-0.09%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.31%
Valuation
Industry RankSector Rank
PE 50.32
Fwd PE 69.67
P/S 6.99
P/FCF 28.52
P/OCF 14.02
P/B 2.42
P/tB 2.42
EV/EBITDA 16.45
EPS(TTM)2.04
EY1.99%
EPS(NY)1.47
Fwd EY1.44%
FCF(TTM)3.6
FCFY3.51%
OCF(TTM)7.32
OCFY7.13%
SpS14.68
BVpS42.45
TBVpS42.45
PEG (NY)N/A
PEG (5Y)116.75
Graham Number44.14
Profitability
Industry RankSector Rank
ROA 2.97%
ROE 5.92%
ROCE 3.34%
ROIC 2.64%
ROICexc 2.65%
ROICexgc 2.73%
OM 18.25%
PM (TTM) 17.11%
GM 61.28%
FCFM 24.51%
ROA(3y)4.38%
ROA(5y)3.73%
ROE(3y)8.22%
ROE(5y)7.1%
ROIC(3y)2.74%
ROIC(5y)2.62%
ROICexc(3y)2.77%
ROICexc(5y)2.72%
ROICexgc(3y)2.85%
ROICexgc(5y)2.8%
ROCE(3y)3.46%
ROCE(5y)3.32%
ROICexgc growth 3Y0.86%
ROICexgc growth 5Y-2.21%
ROICexc growth 3Y1.1%
ROICexc growth 5Y-2.02%
OM growth 3Y-0.89%
OM growth 5Y-4.58%
PM growth 3Y-26.44%
PM growth 5Y-13.1%
GM growth 3Y0.19%
GM growth 5Y-0.06%
F-Score5
Asset Turnover0.17
Health
Industry RankSector Rank
Debt/Equity 0.82
Debt/FCF 9.72
Debt/EBITDA 4.19
Cap/Depr 65.56%
Cap/Sales 25.33%
Interest Coverage 2.06
Cash Conversion 87.62%
Profit Quality 143.24%
Current Ratio 0.07
Quick Ratio 0.07
Altman-Z 1.52
F-Score5
WACC7.31%
ROIC/WACC0.36
Cap/Depr(3y)72.34%
Cap/Depr(5y)87.06%
Cap/Sales(3y)27.91%
Cap/Sales(5y)32.43%
Profit Quality(3y)124.82%
Profit Quality(5y)99.59%
High Growth Momentum
Growth
EPS 1Y (TTM)-42.37%
EPS 3Y13.97%
EPS 5Y0.43%
EPS Q2Q%194.12%
EPS Next Y-10.21%
EPS Next 2Y-11.47%
EPS Next 3Y0.69%
EPS Next 5YN/A
Revenue 1Y (TTM)1.55%
Revenue growth 3Y10.52%
Revenue growth 5Y8.46%
Sales Q2Q%2.18%
Revenue Next Year2.44%
Revenue Next 2Y2.5%
Revenue Next 3Y3.27%
Revenue Next 5Y4.51%
EBIT growth 1Y-5.72%
EBIT growth 3Y9.54%
EBIT growth 5Y3.5%
EBIT Next Year207.48%
EBIT Next 3Y49.06%
EBIT Next 5Y37.61%
FCF growth 1Y3.98%
FCF growth 3Y36.84%
FCF growth 5Y20.83%
OCF growth 1Y1.43%
OCF growth 3Y10.3%
OCF growth 5Y6.88%

CAMDEN PROPERTY TRUST / CPT FAQ

What is the fundamental rating for CPT stock?

ChartMill assigns a fundamental rating of 4 / 10 to CPT.


Can you provide the valuation status for CAMDEN PROPERTY TRUST?

ChartMill assigns a valuation rating of 2 / 10 to CAMDEN PROPERTY TRUST (CPT). This can be considered as Overvalued.


Can you provide the profitability details for CAMDEN PROPERTY TRUST?

CAMDEN PROPERTY TRUST (CPT) has a profitability rating of 5 / 10.


Can you provide the financial health for CPT stock?

The financial health rating of CAMDEN PROPERTY TRUST (CPT) is 3 / 10.


What is the earnings growth outlook for CAMDEN PROPERTY TRUST?

The Earnings per Share (EPS) of CAMDEN PROPERTY TRUST (CPT) is expected to decline by -10.21% in the next year.